http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Proposed Legislative Changes Affecting Pharmaceutical Patents
Reviews proposed legislative changes to the Drug Price Competition and Patent Term Restoration Act of 1984, known as the Hatch-Waxman Act, which revised patent laws as applied to pharmaceutical products. Discusses general provisions of the law, selected patent-related issues, an FTC report on abbreviated new drug applications, an FDA rule change regarding requirements for listing pharmaceutical patents in the Orange Book, and various legislative proposals in the 108th Congress to amend the Hatch-Waxman Act.
Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Dec. 2010). Reuse except for individual research requires license from ProQuest, LLC.
Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
Library of Congress. Congressional Research Service.